Organon initiates Phase 3 trial of Tapinarof cream for atopic dermatitis in infants
Organon has initiated a global Phase 3 clinical trial to assess the safety and efficacy of Tapinarof cream, 1%, in infants aged 3 to 23 months diagnosed with atopic dermatitis.